Patent · US Expired

Immunologic assay to determine C-peptide containing impurities in samples of human insulin and derivatives thereof

US7169562B1 · kind B1 · utility

0Cited by

3References

12Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Martin Gerl · Kriftel, DE
Cornelia Steinert · Wiesbaden, DE

Key dates

Filing date	Oct 26, 2000
Grant date	Jan 30, 2007
Priority date	—
Expiry date	Feb 11, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/105831
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a process for detecting or determining a C-peptide-containing impurity in a sample of recombinantly produced human insulin or a derivative thereof, by a non-radioactive assay, comprising the steps:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.